ADAR1 is an enzyme that catalyzes adenosine-to-inosine (A-to-I) RNA editing, converting adenosines within double-stranded RNA regions into inosine, which is read by the cell as guanosine. It is expressed as two isoforms: a constitutively expressed, predominantly nuclear p110 isoform, and an interferon-inducible, predominantly cytoplasmic p150 isoform. By editing self double-stranded RNA, ADAR1 is a central mechanism by which cells prevent their own endogenous RNA from being mistaken for viral RNA and triggering an inappropriate innate immune response; loss of ADAR1 function causes embryonic lethality and autoinflammatory disease in mice and humans, respectively, while ADAR1 upregulation is frequently exploited by cancer cells for immune evasion.
Related terms
Source papers
- DDX6 induces immunosuppression in cancer by disrupting structural stability of endogenous double-stranded RNAs doi:10.1126/sciimmunol.aea6909